Effects of the levonorgestrel-releasing intrauterine system on urinary symptoms in patients with adenomyosis
article
OA: closed
CC0
⤵ 12 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the impact of the levonorgestrel-releasing intrauterine system on urinary symptoms in patients diagnosed with adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (22)
- Adenomyosis in endometriosis – prevalence and impact on fertility. Evidence from magnetic resonance imaging via openalex
- Adenomyosis in endometriosis—prevalence and impact on fertility. Evidence from magnetic resonance imaging via openalex
- Adenomyosis: New Knowledge is Generating New Treatment Strategies via openalex
- Adenomyosis: sonographic findings and diagnostic accuracy. via openalex
- Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis via openalex
- Cytokine Network of Eutopic and Ectopic Endometrium in Women with Adenomyosis via openalex
- Expression of interleukin-8 and monocyte chemotactic protein-1 in adenomyosis via openalex
- Medical and surgical management of adenomyosis via openalex
- Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)—A systematic enquiry and overview via openalex
- Overactive bladder symptoms and uterine adenomyosis—is there any connection? via openalex
- Therapeutic options for adenomyosis: a review via openalex
- Transvaginal Ultrasound in the Diagnosis of Diffuse Adenomyosis via openalex
- W6628868091 via openalex
- W1485200210 via openalex
- W1863072841 via openalex
- W1968357740 via openalex
- W2036973129 via openalex
- W2042662817 via openalex
- W2049770239 via openalex
- W2115544934 via openalex
- W2164017484 via openalex
- W1484742242 via openalex
Cited by (12)
- Fertility outcome following ovarian stimulation in infertile women having pretreatment with levonorgestrel releasing intrauterine system versus dienogest for symptomatic adenomyosis 2025
- Long-term efficacy and safety of levonorgestrel releasing intrauterine system in the treatment of adenomyosis: evidence mapping 2024
- The clinical effect of dienogest on urinary and sexual symptoms in endometriosis patients 2024
- Evaluation of Endpoints Used in Clinical Trials on Adenomyosis - ASystematic Review 2023
- Long-term Efficacy and Safety of Levonorgestrel - releasing Intrauterine System in the Treatment of Adenomyosis: Evidence Mapping and Meta-analysis 2022
- Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review 2022
- Medical Treatment of Adenomyosis 2022
- A systematic review of outcome reporting and outcome measures in studies investigating uterine-sparing treatment for adenomyosis 2021
- Adenomiosis. Una gran desconocida: ¿Qué debemos saber? 2020
- Development of a clinical prediction model for diagnosing adenomyosis 2018
- Adenomyosis and urinary system symptoms 2018
- Menorrhagia and Uterine Volume Associated with Lower Urinary Tract Symptoms in Patients with Adenomyosis 2017
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:18:53.335890+00:00
License: CC0
· commercial use OK